<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Ophthalmol</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Ophthalmol</journal-id>
      <journal-title-group>
        <journal-title>BMC Ophthalmology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1471-2415</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26310495</article-id>
      <article-id pub-id-type="pmc">4551527</article-id>
      <article-id pub-id-type="publisher-id">105</article-id>
      <article-id pub-id-type="doi">10.1186/s12886-015-0105-0</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Profound hypotony maculopathy in a first episode of bilateral idiopathic acute anterior uveitis</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Edmunds</surname>
            <given-names>Matthew R.</given-names>
          </name>
          <address>
            <email>m.r.edmunds@bham.ac.uk</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Madge</surname>
            <given-names>Simon N.</given-names>
          </name>
          <address>
            <email>simon.madge@wvt.nhs.uk</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <aff id="Aff1"><label/>Academic Unit of Ophthalmology, University of Birmingham, Birmingham &amp; Midland Eye Centre, Dudley Road, Birmingham, B18 7QH UK </aff>
        <aff id="Aff2"><label/>Hereford County Hospital, Stonebow Road, Hereford, HR1 2BN UK </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>28</day>
        <month>8</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>28</day>
        <month>8</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2015</year>
      </pub-date>
      <volume>15</volume>
      <elocation-id>116</elocation-id>
      <history>
        <date date-type="received">
          <day>27</day>
          <month>6</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>14</day>
          <month>8</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Edmunds and Madge. 2015</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>We report a case of a HLA-B27 negative patient presenting with severe, bilateral, idiopathic acute anterior uveitis with acute hypotony and hypotony maculopathy as their first uveitic episode.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>Within a week of onset of her first episode of acute anterior uveitis, a 45&#xA0;year-old Caucasian lady developed profound ocular hypotony with unrecordable intraocular pressures, reduced vision and choroidal folds. All investigations were negative. Uveitic hypotony responded slowly to corticosteroids &#x2013; intravenous, oral and topical &#x2013; with normalization of intraocular pressure and resolution of choroidal folds after two months. Anterior uveitis and hypotony have not returned with six months of follow-up.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>Bilateral, profound hypotony maculopathy may present acutely in idiopathic acute anterior uveitis, may be slow to respond to treatment and should be considered as a cause of vision loss in patients with this condition.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Anterior Uveitis</kwd>
        <kwd>Hypotony</kwd>
        <kwd>Hypotony Maculopathy</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2015</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Background</title>
      <p>Ocular hypotony is a known complication of trauma, chronic retinal detachment, vitreoretinal or glaucoma filtration surgery (particularly with the use of Mitomycin-C), as well as uveitis [<xref ref-type="bibr" rid="CR1">1</xref>]. Maculopathy associated with hypotony is important as it is associated with reduced visual acuity in a high proportion of patients and may be challenging to treat [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. Previous cases of hypotony in the context of HLA-B27 have been reported, likely due to ciliary body inflammation with reduced aqueous production, or increased uveoscleral outflow [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. We report an unusual case of bilateral profound, prolonged hypotony with maculopathy in the context of a patient&#x2019;s first episode of idiopathic acute anterior uveitis.</p>
    </sec>
    <sec id="Sec2">
      <title>Case presentation</title>
      <p>A 45-year-old Caucasian lady, with no significant past ocular or medical history, presented with bilateral ocular pain, redness and photophobia. Visual acuities at first attendance were 6/9 OU. She had evidence of 3+ anterior chamber cells and 2+ flare bilaterally with no fibrin, hypopyon or posterior synechiae. There was no vitritis or retinitis. Initial intraocular pressures (IOP) were 10&#xA0;mmHg OU by Goldmann applanation tonometry (GAT). There were no systemic symptoms, no predisposing factors for uveitis and no personal or family history of HLA-B27-related disease. The patient was commenced on regular guttae Dexamethasone 0.1 % six times per day and Cyclopentolate 1 % twice daily.</p>
      <p>On review one week later visual acuities had deteriorated to hand movements at one metre, bilaterally. Anterior chamber activity was unchanged but intraocular pressures were now unrecordable and there were bilateral Descemet&#x2019;s membrane folds. Fundal examination revealed bilateral choroidal folds (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1a</xref> and <xref rid="Fig1" ref-type="fig">b</xref>), with optical coherence tomography confirming no cystoid macular edema or epiretinal membrane (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1c</xref> and <xref rid="Fig1" ref-type="fig">d</xref>). There was no evidence of optic disc edema, peripheral choroidal detachment or exudative retinal detachment. Gonioscopy revealed open iridocorneal angles.<fig id="Fig1"><label>Fig. 1</label><caption><p>Color fundus photographs of right (<bold>a</bold>) and left (<bold>b</bold>) eyes demonstrating poor hazy view, principally due to Descemet&#x2019;s membrane folds. There was no evidence of vitreous activity. Optical coherence tomography images of the right (<bold>c</bold>) and left (<bold>d</bold>) macula with irregular retinal contour, further demonstrated on OCT thickness map of the right (<bold>e</bold>) and left (<bold>f</bold>) macula</p></caption><graphic xlink:href="12886_2015_105_Fig1_HTML" id="MO1"/></fig></p>
      <p>A diagnosis was made of hypotony maculopathy secondary to acute anterior uveitis with iridocyclitis. She was commenced on guttae Prednisolone 1 % hourly and Atropine 1 % twice daily and received intravenous methylprednisolone 1&#xA0;g on three consecutive days, before continuing with oral Prednisolone 60&#xA0;mg, reducing gradually over the next several months.</p>
      <p>All investigations were unremarkable, with normal full blood count, urea and electrolytes, c-reactive protein and erythrocyte sedimentation rate, angiotensin converting enzyme, anti-nuclear antibodies, anti-neutrophil cytoplasmic antibodies, immunoglobulins, complement C3 and C4 and protein electrophoresis. Treponemal and Bartonella serology were negative, as was that for HIV. HLA-B27 was negative. Chest X-ray demonstrated no abnormality. No aqueous sample or vitreous biopsy was taken.</p>
      <p>Hypotony continued for the next two months, with IOP measured at 2 &#x2013; 4&#xA0;mmHg bilaterally and visual acuities varying between hand movements and 6/24, but eventually stabilized with IOP of 13&#xA0;mmHg on each side. With resolution of hypotony maculopathy visual acuities returned to 6/6 OU. The patient&#x2019;s vision remains stable with no further episodes of anterior uveitis or hypotony, six months after resolution of the episode.</p>
    </sec>
    <sec id="Sec3" sec-type="discussion">
      <title>Discussion</title>
      <p>To our knowledge this is the first report of a HLA-B27 negative patient presenting with acute hypotony in their first uveitic episode. Chronic uveitic hypotony is more common than acute hypotony. While chronic cases are thought to develop due to prolonged inflammatory activity, with ciliary body atrophy or the development of cyclitic membranes, acute hypotony in uveitis has been proposed to be due to ciliary body inflammation, with reduced aqueous production, or increased uveoscleral outflow [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>].</p>
      <p>Both acute and chronic hypotony may result in hypotony maculopathy, optic nerve edema, exudative retinal detachment and choroidal folds, although acute cases are more likely to be reversible and less likely to be associated with phthisis bulbi [<xref ref-type="bibr" rid="CR2">2</xref>]. Nevertheless, a high proportion of patients with uveitic hypotony have significantly reduced vision, with one cohort determining that 84.1 % of eyes presenting with hypotony had a visual acuity of 20/200 or worse [<xref ref-type="bibr" rid="CR3">3</xref>].</p>
      <p>The published prevalence of hypotony related to uveitis varies depending on the patient cohort. In the Multicenter Uveitis Steroid Treatment (MUST) Trial, in which hypotony was defined as an eye with IOP of &lt;7&#xA0;mmHg at the baseline visit or an eye with a history of hypotony and an IOP of &lt;9&#xA0;mmHg at the baseline visit, 8.3 % of 240 uveitic patients had hypotony. Mean IOP in hypotonous eyes in the MUST Trial was 4.6&#xA0;mmHg and hypotony was bilateral in only three cases (1.25 %) [<xref ref-type="bibr" rid="CR2">2</xref>].</p>
      <p>However, only 1.86 % of 6785 patients in a non-infectious uveitis cohort from the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) cohort developed hypotony, equivalent to an incidence of 0.006 per person-year. In this cohort hypotony was defined as IOP &lt;5&#xA0;mmHg sustained for &#x2265;2 visits spanning at least 30&#xA0;days. Of 11,119 eyes in 6545 patients uveitic patients, 189 eyes (1.7 %) of 161 patients presented with hypotony (IOP &lt;5&#xA0;mmHg), with 28 (17.4 % of the hypotonous patients, 0.4 % of the total patients) presenting with bilateral hypotony [<xref ref-type="bibr" rid="CR3">3</xref>]. It is uncertain how many of these patients were presenting with their first episode of uveitis as some were commented to have band keratopathy.</p>
      <p>In these cohorts hypotony was found to be more common in patients with greater duration of uveitis (&#x2265;5&#xA0;years) or with a history of previous ocular surgery (e.g. cataract surgery, pars plana vitrectomy). Furthermore, those of African-American ethnic origin, with hypertension or diabetes mellitus and uveitis from a younger age had more hypotony. Hypotony was also more common in anterior than intermediate or posterior uveitis and in those with more severe uveitis (e.g. anterior chamber flare of +1 or more, posterior synechiae and pars planitis) [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. In the study of Daniel et al. [<xref ref-type="bibr" rid="CR3">3</xref>], patients with panuveitis had the highest prevalence of hypotony (4.8 %), followed by anterior uveitis (1.8 %), posterior uveitis (0.6 %) and intermediate uveitis (0.3 %). Rates of hypotony in pediatric uveitis, particularly JIA-associated uveitis (often an anterior uveitis) are higher [<xref ref-type="bibr" rid="CR6">6</xref>].</p>
      <p>Hypotony maculopathy has previously been described in patients with anterior uveitis associated with HLA-B27, but our patient was HLA-B27 negative. Of the six HLA-B27 positive patients in the literature with uveitic hypotony, only one had bilateral anterior uveitis and hypotony [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. This was a 61-year-old male with left hypopyon, right fibrinous uveitis and bilateral vitritis, seemingly a much more severe uveitic case than the patient we present [<xref ref-type="bibr" rid="CR5">5</xref>].</p>
    </sec>
    <sec id="Sec4" sec-type="conclusion">
      <title>Conclusion</title>
      <p>To our knowledge this is the first report in the literature of a HLA-B27 negative patient presenting with their first episode of bilateral idiopathic acute anterior uveitis characterized by profound hypotony and hypotony maculopathy, and who responded slowly but completely to topical and systemic corticosteroid. Ophthalmologists will be aware of hypotony in the context of chronic or recurrent uveitis, but should also be aware of such significant and debilitating hypotony in those previously na&#xEF;ve to intraocular inflammation.</p>
    </sec>
    <sec id="Sec5">
      <title>Consent</title>
      <p>Written informed consent was obtained from the patient for publication of this Case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.</p>
    </sec>
  </body>
  <back>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>GAT</term>
          <def>
            <p>Goldmann applanation tonometry</p>
          </def>
        </def-item>
        <def-item>
          <term>HIV</term>
          <def>
            <p>Human immunodeficiency virus</p>
          </def>
        </def-item>
        <def-item>
          <term>HLA-B27</term>
          <def>
            <p>Human leucocyte antigen B27</p>
          </def>
        </def-item>
        <def-item>
          <term>IOP</term>
          <def>
            <p>Intraocular pressure</p>
          </def>
        </def-item>
        <def-item>
          <term>mmHg</term>
          <def>
            <p>Millimetres of mercury</p>
          </def>
        </def-item>
        <def-item>
          <term>MUST</term>
          <def>
            <p>Multicenter Uveitis Steroid Treatment</p>
          </def>
        </def-item>
        <def-item>
          <term>OU</term>
          <def>
            <p>Oculus uterque (both eyes)</p>
          </def>
        </def-item>
        <def-item>
          <term>SITE</term>
          <def>
            <p>Systemic Immunosuppressive Therapy for Eye Diseases</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors declare that they have no competing interests. The authors alone are responsible for the content and writing of the paper.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors&#x2019; contributions</bold>
        </p>
        <p>ME and SM drafted the manuscript and have each approved the final version.</p>
      </fn>
    </fn-group>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fannin</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Schiffman</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Budenz</surname>
              <given-names>DL</given-names>
            </name>
          </person-group>
          <article-title>Risk factors for hypotony maculopathy</article-title>
          <source>Ophthalmology</source>
          <year>2003</year>
          <volume>110</volume>
          <fpage>1185</fpage>
          <lpage>91</lpage>
          <pub-id pub-id-type="doi">10.1016/S0161-6420(03)00227-6</pub-id>
          <pub-id pub-id-type="pmid">12799246</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <mixed-citation publication-type="other">Sen HN, Drye LT, Goldstein DA, Larson TA,&#xA0;Merrill PT,&#xA0;Pavan PR,&#xA0;Sheppard JD,&#xA0;Burke A,&#xA0;Srivastava SK,&#xA0;Jabs DA; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group. Hypotony in patients with uveitis: the Multicenter Uveitis Steroid Treatment (MUST) Trial. Ocul Immunol Inflamm. 2012;20:104&#x2013;12.</mixed-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Daniel</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Pistilli</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Pujari</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Ka&#xE7;maz</surname>
              <given-names>RO</given-names>
            </name>
            <name>
              <surname>Nussenblatt</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Rosenbaum</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Suhler</surname>
              <given-names>EB</given-names>
            </name>
            <name>
              <surname>Thorne</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Foster</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Jabs</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Levy-Clarke</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Kempen</surname>
              <given-names>JH</given-names>
            </name>
          </person-group>
          <article-title>Risk of hypotony in noninfectious uveitis</article-title>
          <source>Ophthalmology</source>
          <year>2012</year>
          <volume>119</volume>
          <fpage>2377</fpage>
          <lpage>85</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ophtha.2012.05.032</pub-id>
          <pub-id pub-id-type="pmid">22796306</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roe</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Branco</surname>
              <given-names>BC</given-names>
            </name>
            <name>
              <surname>Cunningham</surname>
              <given-names>ET</given-names>
              <suffix>Jr</suffix>
            </name>
          </person-group>
          <article-title>Hypotony maculopathy in a patient with HLA-B27-associated uveitis</article-title>
          <source>Ocul Immunol Inflamm</source>
          <year>2008</year>
          <volume>16</volume>
          <fpage>107</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1080/09273940802023794</pub-id>
          <pub-id pub-id-type="pmid">18569798</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van der Veer</surname>
              <given-names>EG</given-names>
            </name>
            <name>
              <surname>Keunen</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Rothova</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Severe HLA B27-associated uveitis complicated by hypotony, serous retinal detachment, and ciliochoroidal effusion</article-title>
          <source>Ocul Immunol Inflamm</source>
          <year>2014</year>
          <volume>22</volume>
          <fpage>23</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.3109/09273948.2013.828081</pub-id>
          <pub-id pub-id-type="pmid">24063542</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thorne</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Woreta</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Kedhar</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Dunn</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Jabs</surname>
              <given-names>DA</given-names>
            </name>
          </person-group>
          <article-title>Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss</article-title>
          <source>Am J Ophthalmol</source>
          <year>2007</year>
          <volume>143</volume>
          <fpage>840</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ajo.2007.01.033</pub-id>
          <pub-id pub-id-type="pmid">17362866</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
